ERYTHROMYCIN STEARATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for erythromycin stearate and what is the scope of freedom to operate?

Erythromycin stearate is the generic ingredient in eight branded drugs marketed by Bristol, Parke Davis, Warner Chilcott, Azurity, Ani Pharms, Lederle, Norvium Bioscience, Purepac Pharm, Watson Labs, Bristol Myers Squibb, Pfizer, and Wyeth Ayerst, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for erythromycin stearate.

Summary for ERYTHROMYCIN STEARATE

US Patents:	0
Tradenames:	8
Applicants:	12
NDAs:	15
Drug Master File Entries:	18
Raw Ingredient (Bulk) Api Vendors:	128
Clinical Trials:	1
Patent Applications:	7,511
Drug Prices:	Drug price trends for ERYTHROMYCIN STEARATE
What excipients (inactive ingredients) are in ERYTHROMYCIN STEARATE?	ERYTHROMYCIN STEARATE excipients list
DailyMed Link:	ERYTHROMYCIN STEARATE at DailyMed

See drug prices for ERYTHROMYCIN STEARATE

Recent Clinical Trials for ERYTHROMYCIN STEARATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Chr Hansen	N/A
Ryerson University	N/A
Chr Hansen A/S	N/A

See all ERYTHROMYCIN STEARATE clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ERYTHROMYCIN STEARATE

US Patents and Regulatory Information for ERYTHROMYCIN STEARATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lederle	ERYTHROMYCIN STEARATE	erythromycin stearate	TABLET;ORAL	062089-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Norvium Bioscience	ERYTHROMYCIN STEARATE	erythromycin stearate	TABLET;ORAL	061505-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer	PFIZER-E	erythromycin stearate	TABLET;ORAL	061791-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.